Drug Discovery
ByIs Sanofi Strengthening Its Adult Vaccine Strategy with a $2.2 Billion Dynavax Deal?
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by announcing a $2.2…
Has Sanofi’s Dupixent Been Approved for Pediatric Asthma in Japan?
Tokyo, Japan – December 23, 2025 Sanofi and Regeneron have received regulatory approval in Japan for Dupixent (dupilumab)…
U.S. FDA Approves JASCAYD® for Progressive Pulmonary Fibrosis – A New Treatment Option for Adults?
Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has approved JASCAYD® (nerandomilast) tablets for the…
Are Galux and Boehringer Ingelheim Pioneering AI in Precision Protein Design?
December 17, 2025 — Galux, a South Korean biotech company focused on AI-driven protein therapeutics, has entered a…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…
